Cargando…
Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers
New therapeutic modalities for melanoma promise benefit in selected individuals. Efficacy appears greater in patients with lower tumor burden, suggesting an important role for risk‐stratified surveillance. Robust predictive markers might permit optimization of agent to patient, while low‐risk progno...
Autores principales: | Hyams, David M., Cook, Robert W., Buzaid, Antonio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590387/ https://www.ncbi.nlm.nih.gov/pubmed/30548543 http://dx.doi.org/10.1002/jso.25319 |
Ejemplares similares
-
Management of metastatic cutaneous melanoma: updates in clinical practice
por: Schvartsman, Gustavo, et al.
Publicado: (2019) -
Staging of cutaneous melanoma
por: Mohr, P., et al.
Publicado: (2009) -
Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma
por: Zeng, Hao, et al.
Publicado: (2021) -
The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
por: Huang, Runzhi, et al.
Publicado: (2022) -
Prognostic factors for metastasis in cutaneous melanoma
por: Cherobin, Ana Carolina Figueiredo Pereira, et al.
Publicado: (2018)